首页 | 本学科首页   官方微博 | 高级检索  
检索        

戒烟药物研究进展
引用本文:黄琼,徐爱晖.戒烟药物研究进展[J].中国慢性病预防与控制,2010,18(3):323-325.
作者姓名:黄琼  徐爱晖
作者单位:安徽医科大学第一附属医院呼吸内科,安徽,合肥,230032
摘    要:烟草危害人类健康,戒烟已经迫在眉睫。国际公认的戒烟药物有7种,包括5种尼古丁替代制剂、安非他酮缓释剂和伐尼克兰。尼古丁替代疗法是用纯净医用尼古丁代替烟雾中吸入的尼古丁;安非他酮缓释剂是种氨基酮类抗抑郁剂。通过增加中枢NE、5-HT及DA含量,两者都可减少戒断症状。伐尼克兰是种选择性烟碱受体部分激动剂,可竞争性的与α4β2尼古丁乙酰胆碱受体结合但部分激活受体,引起减半的受体应答效应,从而起到降低吸烟渴求和减少戒断症状的发生。对目前的戒烟药物现状作一综述。

关 键 词:戒烟  伐尼克兰  尼古丁替代疗法  安非他酮缓释剂

Progress in Smoking Cessation Drugs
HUANG Qiong,XU Ai-hui.Progress in Smoking Cessation Drugs[J].Chinese Journal of Prevention and Control of Chronic Non-Communicable Diseases,2010,18(3):323-325.
Authors:HUANG Qiong  XU Ai-hui
Institution:. (The Department of Respiratory Disease, the First Affiliated Hospital of A nhu.i Medical University, Hefei 230032, China)
Abstract:Tobacco Smoking hazards to people's health, it's the time to encourage people to quit smoking. There are seven kinds of drugs which are used to quit smoking, including five nicotine replacement agents, Bupropion SR and varenicline. Nicotine replacement therapy is to use pure medical nicotine to replace nicotine in smoking, Bupropion SR is amino-ketone thymoleptics, both can treat nicotine dependence; Varenicline is a partial agonist selective for et4132 nicotinic acetylcholine receptor subtypes. Varenicline binds with high '~nity and selective at 0t4132 nicotinic acetylcholine receptors, blocks the ability of nicotine to activate ~132 nicotinic receptors and thus blocks the nervous transmission underlying reinforcement and reward experienced upon smoking, then reduces the craving for smoking and occurrence of nicotine withdrawal symptoms.
Keywords:Smoking cessation  Varenicline  Nicotine replacement therapy  Bupropion SR
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号